Umbilical Cord Blood Transplant for Malignancies: A Hope or Hype
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Cord blood is a rich and unlimited source of hematopoietic stem cells for allogeneic stem cell transplant to treat a variety of oncologic, genetic, hematologic, and immunodeficiency disorders. Since the first successful cord blood transplant in 1988, a large number of cord blood banks have been established world over for collection and storage of cord blood for future use. Majority of such transplants are performed in children, however, the number in adults have been growing steadily in recent years. Results from various transplant registries reveals that a single cord blood provides enough stem cells to provide short and long term engraftment, and has low incidence and less severity of graft versus host disease. With a high booming birth rate and a large genetic diversity, India has potential to become the largest supplier of cord blood stem cells in world. To meet the future transplant need of the country sincere efforts from various institutes and government agencies are needed to increase the number of public cord blood banks in the country. In this article the author will focus on the issue of public and private cord blood banking; the role of physicians in educating and counseling families with regard to the utility of cord blood for donor itself as well as the future of umbilical cord blood transplant in India.
- Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, et al. Results of the cord blood transplantation study (COBLT): Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006;12:184–94. CrossRef
- Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: Influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–89. CrossRef
- Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8. CrossRef
- http://www.bmdw.org. Assessed on August 14, 2012.
- http://www.nmdp.org. Assessed on August 14, 2012.
- Gluckman E. Ten years of cord blood transplantation: From bench to bedside. Br J Haematol. 2009;147:192–9. CrossRef
- Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.
- Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet. 2007;369:1947–54. CrossRef
- Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75. CrossRef
- Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2007;13:444–53. CrossRef
- Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007;109:1322–30. CrossRef
- Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood. 1994;83:2410–7.
- Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91:9857–60. CrossRef
- Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373–81. CrossRef
- Rubinstein P, Carrier C, Scaradavou M, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77. CrossRef
- Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. 2001;98:2332–8. CrossRef
- Iseki T, Ooi J, Tomonari A, Takahashi T, Ishii K, Uchimaru K, et al. Unrelated cord blood transplantation in adult patients with hematological malignancy: A single institution experience. Blood. 2001;98:665a.
- Rocha V, Arcese W, Sanz G, Laporte JP, Takahashi T, Fernandez M, et al. Prognostic factors of outcome after unrelated cord blood transplant in adults with hematologic malignancies. Blood. 2000;96:587a.
- Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–22. CrossRef
- Cord blood registry. Why you should save blood for your family. Available from http://www.cordblood.com/cord_blood_banking_with_cbr/banking/diseases_treated.asp?fbid=BlyS_OAIG4n, assessed on August 14, 2012.
- Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer. 2003;3:526–32. CrossRef
- Rebulla P. Cord blood banking 2002: 112,010 of 7,914,773 chances. Transfusion. 2002;42:1246–8. CrossRef
- Moise KJ Jr. Umbilical cord stem cells. Obstet Gynecol. 2005;106:1393–407. CrossRef
- Reed W, Smith R, Dekovic F, Lee JY, Saba JD, Trachtenberg E, et al. Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood. 2003;101:351–7. CrossRef
- Lasky LC, Lane TA, Miller JP, Lindgren B, Patterson HA, Haley NR, et al. In utero or ex utero cord blood collection: Which is better? Transfusion. 2002;42:1261–7. CrossRef
- Wong A, Yuen PM, Li K, Yu AL, Tsoi WC. Cord blood collection before and after placental delivery: Levels of nucleated cells, haematopoieticprogenitor cells, leukocyte subpopulations and macroscopic clots. Bone Marrow Transplant. 2001;27:133–8. CrossRef
- Eichler H, Meckies J, Schmut N, Kern S, Klüter H, Zieger W. Aspects of donation and processing of stem cell transplants from umbilical cord blood. Z Geburtshilfe Neonatol. 2001;205:218–23. CrossRef
- Nakagawa R, Watanabe T, Kawano Y, Kanai S, Suzuya H, Kaneko M, et al. Chugoku-Shikoku cord blood bank. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion. 2004;44:262–7. CrossRef
- Solves P, Perales A, Mirabet V, Roig R. Stress factors and umbilical cord blood banking. Transfus Med. 2007;17:205–6. CrossRef
- Kudo Y, Minegishi M, Seki O, Takahashi H, Suzuki A, Narita A, et al. Quality assessment of umbilical cord blood units at the time of transplantation. Int J Hematol. 2011;93:645–51. CrossRef
- Querol S, Rubinstein P, Marsh SG, Goldman J, Madrigal JA. Cord blood banking: ‘Providing cord blood banking for a nation’. Br J Haematol. 2009;147:227–35. CrossRef
- Gluckman E, Eurocord Netcord Organisation. Ethical and legal aspects of placental/cord blood banking and transplant. Hematol J. 2000;1:67–9. CrossRef
- Burgio GR, Gluckman E, Locatelli F. Ethical reappraisal of 15 years of cord-blood transplantation. Lancet. 2003;361:250–2. CrossRef
- American Academy of Pediatrics Section on Hematology/Oncology, American Academy of Pediatrics Section on Allergy/Immunology, Lubin BH, Shearer WT. Cord blood banking for potential future transplantation. Pediatrics. 2007;119:165–70. CrossRef
- Committee on Obstetric Practice, Committee on Genetics. ACOG committee opinion number 399, February 2008: Umbilical cord blood banking. Obstet Gynecol. 2008;111:475–7. CrossRef
- Sullivan MJ. Banking on cord blood stem cells. Nat Rev Cancer. 2008;8:555–63. CrossRef
- Rocha V, Crotta A, Ruggeri A, Purtill D, Boudjedir K, Herr AL, et al; Eurocord Registry. Double cord blood transplantation: Extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol. 2010;23:223–9.
- Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–9. CrossRef
- Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy. 2004;6:344–55. CrossRef
- Christopherson 2nd KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol. 2002;169:7000–8.
- Frassoni F, Gualandi F, Podestà M, Raiola AM, Ibatici A, Piaggio G, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol. 2008;9:831–9. CrossRef
- Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood. 1999;93:3662–71.
- Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al; Eurocord Registry. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137–43.
- Petterson TE, Gabriel M, Tiedemann K, Teague L, Shaw PJ, Baker D, et al. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: A report from the Australian and New Zealand children’s haematology and oncology group. Bone Marrow Transplant. 2009;43:207–15. CrossRef
- ICMR-DBT guidelines for stem cell research and therapy 2006; http://medind.nic.inby/to6/i9/ibyt06i9p361.pdf, assessed on August 14, 2012.
- http://www.parentsguidecordblood.org/content/USA/blacklist/regulation.Shtml?navid=31#india, assessed on August 14, 2012.
- Yadav SP, Sachdeva A, Bhat S, Katewa S. Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion. Pediatr Hematol Oncol. 2010;27:24–30. CrossRef
- Bhat S, Sachdeva A, Lall M, Anjan M, Kalra M, Katewa S, et al. Evolution of a new malignant clone post unrelated umbilical cord blood transplantation for acute myeloid leukemia with monosomy 7. Pediatr Blood Cancer. 2009;53:780 (abstract PA.066).
- Umbilical Cord Blood Transplant for Malignancies: A Hope or Hype
The Indian Journal of Pediatrics
Volume 80, Issue 8 , pp 675-680
- Cover Date
- Print ISSN
- Online ISSN
- Springer India
- Additional Links
- Umbilical cord blood
- Stem cells
- Industry Sectors